Clinical Trials Logo

Spray clinical trials

View clinical trials related to Spray.

Filter by:
  • None
  • Page 1

NCT ID: NCT04277494 Recruiting - Athletic Injuries Clinical Trials

The Acute Effect of Cold Spray Application on the Mechanical Properties of the Quadriceps Muscle in Athletes

Start date: January 12, 2020
Phase: N/A
Study type: Interventional

Vikocoolant spray, also known as cold spray; It is a form of cryotherapy (cold treatment) used in sports medicine, athletic training, sports competitions and rehabilitation environments. It has been demonstrated in the literature that local cold application may cause increased resistance to movement. It has been reported in some studies that muscle can change its mechanical properties in a short time. However, the effect of cold spray application on the mechanical properties of the muscle is unknown. Therefore, in the current study proposal, the investigators aim to investigate the acute effect of cold spray application on the mechanical properties of the quadriceps muscle in athletes.

NCT ID: NCT04207710 Completed - Pain Clinical Trials

Safety of Gebauer's Pain Ease and Gebauer's Ethyl Chloride

Start date: January 26, 2021
Phase: Phase 4
Study type: Interventional

This study aims to determine if Gebauer's Pain Ease or Gebauer's Ethyl Chloride topical anesthetic sprays are safe for use as numbing agents prior to placing epidurals and arterial lines, based on whether they introduce increased microbial growth after application to skin. Due to the recent national shortage of lidocaine, we hope to find a suitable alternative to lidocaine for topical analgesia when placing arterial lines and epidurals. Our hypothesis is that the sprays will not affect the sterility of the area. We will compare microbial growth from three subsequent swabs taken from a single area of skin on the wrist and lower back: one with no treatment, the second after treatment with ChloraPrep, and the third after applying one of the numbing sprays. If there is significantly higher growth in the swabs containing the topical anesthetic spray versus the ChloraPrep alone, this will indicate that the sprays introduce microbes to the sites of skin.

NCT ID: NCT03223896 Completed - Gambling Clinical Trials

Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray

NALPILO
Start date: February 14, 2017
Phase: Phase 2
Study type: Interventional

Non-controlled pilot study. Two groups: Group A: naloxone nasal spray max 8 mg/per day; Group B: naloxone max 16 mg/per day. Study duration 8 weeks. Brief intervention.